Máy phát nitric oxide nhạy cảm với kích thích cho liệu pháp quang nhiệt/khí phối hợp điều trị ung thư có điều kiện ánh sáng

Yan, J. J.; Zhang, X. D.; Liu, Y.; Ye, Y. Q.; Yu, J. C.; Chen, Q.; Wang, J. Q.; Zhang, Y. Q.; Hu, Q. Y.; Kang, Y. et al. Shape-controlled synthesis of liquid metal nanodroplets for photothermal therapy. Nano Res., 2019, 12, 1313–1320. Yang, C. Y.; Chen, Y. D.; Guo, W.; Gao, Y.; Song, C. Q.; Zhang, Q.; Zheng, N. N.; Han, X. J.; Guo, C. S. Bismuth ferrite-based nanoplatform design: An ablation mechanism study of solid tumor and NIR-triggered photothermal/photodynamic combination cancer therapy. Adv. Funct. Mater. 2018 28, 1706827. Wang, Y.; Wei, G. Q.; Zhang, X. B.; Xu, F. N.; Xiong, X.; Zhou, S. B. A step-by-step multiple stimuli-responsive nanoplatform for enhancing combined chemo-photodynamic therapy. Adv. Mater. 2017 29, 1605357. Zhao, N.; Wu, B. Y.; Hu, X. L.; Xing, D. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles. Biomaterials 2017 141, 40–49. Han, K.; Zhu, J. Y.; Jia, H. Z.; Wang, S. B.; Li, S. Y.; Zhang, X. Z.; Han, H. Y. Mitochondria-targeted chimeric peptide for trinitarian overcoming of drug resistance. ACS Appl. Mater. Interfaces 2016 8, 25060–25068. Chen, H. B.; Gu, Z. J.; An, H. W.; Chen, C. Y.; Chen, J.; Cui, R.; Chen, S. Q.; Chen, W. H.; Chen, X. S.; Chen, X. Y. et al. Precise nanomedicine for intelligent therapy of cancer. Sci. China Chem. 2018 61, 1503–1552. Li, X. S.; Kwon, N.; Guo, T.; Liu, Z.; Yoon, J. Innovative strategies for hypoxic-tumor photodynamic therapy. Angew. Chem., Int. Ed. 2018 57, 11522–11531. Zhang, W. T.; Li, S. H.; Liu, X. N.; Yang, C. Y.; Hu, N.; Dou, L. N.; Zhao, B. X.; Zhang, Q. Y.; Suo, Y. R.; Wang, J. L. Oxygen-generating MnO2 nanodots-anchored versatile nanoplatform for combined chemo-photodynamic therapy in hypoxic cancer. Adv. Funct. Mater. 2018 28, 1706375. Li, X. S.; Yu, S.; Lee, D.; Kim, G.; Lee, B.; Cho, Y.; Zheng, B. Y.; Ke, M. R.; Huang, J. D.; Nam, K. T. et al. Facile supramolecular approach to nucleic-acid-driven activatable nanotheranostics that overcome drawbacks of photodynamic therapy. ACS Nano 2018 12, 681–688. Deng, K. R.; Li, C. X.; Huang, S. S.; Xing, B. G.; Jin, D. Y.; Zeng, Q. G.; Hou, Z. Y.; Lin, J. Recent progress in near infrared light triggered photodynamic therapy. Small 2017 13, 1702299. Celli, J. P.; Spring, B. Q.; Rizvi, I.; Evans, C. L.; Samkoe, K. S.; Verma, S.; Pogue, B. W.; Hasan, T. Imaging and photodynamic therapy: Mechanisms, monitoring, and optimization. Chem. Rev. 2010 110, 2795–2838. He, H.; Ji, S. S.; He, Y.; Zhu, A. J.; Zou, Y. L.; Deng, Y. B.; Ke, H. T.; Yang, H.; Zhao, Y. L.; Guo, Z. Q. et al. Photoconversion-tunable fluorophore vesicles for wavelength-dependent photoinduced cancer therapy. Adv. Mater. 2017 29, 1606690. Masuda, S.; Izpisua Belmonte, J. C. The microenvironment and resistance to personalized cancer therapy. Nat. Rev. Clin. Oncol. 2013 10, 79. Mo, R.; Gu, Z. Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery. Mater. Today 2016 19, 274–283. Zhu, H. J.; Li, J. C.; Qi, X. Y.; Chen, P.; Pu, K. Y. Oxygenic hybrid semiconducting nanoparticles for enhanced photodynamic therapy. Nano Lett. 2018 18, 586–594. Chen, J.; Luo, H. L.; Liu, Y.; Zhang, W.; Li, H. X.; Luo, T.; Zhang, K.; Zhao, Y. X.; Liu, J. J. Oxygen-self-produced nanoplatform for relieving hypoxia and breaking resistance to sonodynamic treatment of pancreatic cancer. ACS Nano 2017 11, 12849–12862. Chen, H. C.; Tian, J. W.; He, W. J.; Guo, Z. J. H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells. J. Am. Chem. Soc. 2015 137, 1539–1547. Cheng, Y. H.; Cheng, H.; Jiang, C. X.; Qiu, X. F.; Wang, K. K.; Huan, W.; Yuan, A. H.; Wu, J. H.; Hu, Y. Q. Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy. Nat. Commun. 2015 6, 8785. Luo, Z. Y.; Zheng, M. B.; Zhao, P. F.; Chen, Z.; Siu, F. M.; Gong, P.; Gao, G. H.; Sheng, Z. H.; Zheng, C. F.; Ma, Y. F. et al. Self-monitoring artificial red cells with sufficient oxygen supply for enhanced photodynamic therapy. Sci. Rep. 2016 6, 23393. Li, R. Q.; Zhang, C.; Xie, B. R.; Yu, W. Y.; Qiu, W. X.; Cheng, H.; Zhang, X. Z. A two-photon excited O2-evolving nanocomposite for efficient photodynamic therapy against hypoxic tumor. Biomaterials 2019 194, 84–93, DOI: 10.1016/j.biomaterials.2018.12.017. Zhang, C.; Chen, W. H.; Liu, L. H.; Qiu, W. X.; Yu, W. Y.; Zhang, X. Z. An O2 self-supplementing and reactive-oxygen-species-circulating amplified nanoplatform via H2O/H2O2 splitting for tumor imaging and photodynamic therapy. Adv. Funct. Mater. 2017 27, 1700626. Wang, X. Q.; Peng, M. Y.; Li, C. X.; Zhang, Y.; Zhang, M. K.; Tang, Y.; Liu, M. D.; Xie, B. R.; Zhang, X. Z. Real-time imaging of free radicals for mitochondria-targeting hypoxic tumor therapy. Nano Lett. 2018 18, 6804–6811. Rong, Y.; Mack, P. Apoptosis induced by hyperthermia in dunn osteosarcoma cell line in vitro. Int. J. Hyperthermia 2000 16, 19–27. Xiao, Z. Y.; Xu, C. T.; Jiang, X. H.; Zhang, W. L.; Peng, Y. X.; Zou, R. J.; Huang, X. J.; Liu, Q.; Qin, Z. Y.; Hu, J. Q. Hydrophilic bismuth sulfur nanoflower superstructures with an improved photothermal efficiency for ablation of cancer cells. Nano Res. 2016 9, 1934–1947. Ye, S. Y.; Rao, J. M.; Qiu, S. H.; Zhao, J. L.; He, H.; Yan, Z. L.; Yang, T.; Deng, Y. B.; Ke, H. T.; Yang, H. et al. Rational design of conjugated photosensitizers with controllable photoconversion for dually cooperative phototherapy. Adv. Mater. 2018 30, 1801216. Chen, H. B.; Adam, A.; Cheng, Y. F.; Tang, S.; Hartung, J.; Bao, E. D. Localization and expression of heat shock protein 70 with rat myocardial cell damage induced by heat stress in vitro and in vivo. Mol. Med. Rep. 2015 11, 2276–2284. Wei, X.; Liu, L. Q.; Guo, X.; Wang, Y.; Zhao, J. Y.; Zhou, S. B. Lightactivated ROS-responsive nanoplatform codelivering apatinib and doxorubicin for enhanced chemo-photodynamic therapy of multidrug-resistant tumors. ACS Appl. Mater. Interfaces 2018 10, 17672–17684. Wang, Y.; Wei, G. Q.; Zhang, X. B.; Huang, X. H.; Zhao, J. Y.; Guo, X.; Zhou, S. B. Multistage targeting strategy using magnetic composite nanoparticles for synergism of photothermal therapy and chemotherapy. Small 2018 14, 1702994. Chen, Q.; Xu, L. G.; Liang, C.; Wang, C.; Peng, R.; Liu, Z. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy. Nat. Commun. 2016 7, 13193. Tang, P.; Liu, Y. C.; Liu, Y. M.; Meng, H. R.; Liu, Z. Y.; Li, K.; Wu, D. C. Thermochromism-induced temperature self-regulation and alternating photothermal nanohelix clusters for synergistic tumor chemo/photothermal therapy. Biomaterials 2019 188, 12–23. Song, M. L.; Liu, N.; He, L.; Liu, G.; Ling, D. S.; Su, X. H.; Sun, X. L. Porous hollow palladium nanoplatform for imaging-guided trimodal chemo-, photothermal-, and radiotherapy. Nano Res. 2018 11, 2796–2808. Wang, Y. Y.; Deng, Y. B.; Luo, H. H.; Zhu, A. J.; Ke, H. T.; Yang, H.; Chen, H. B. Light-responsive nanoparticles for highly efficient cytoplasmic delivery of anticancer agents. ACS Nano 2017 11, 12134–12144. Huo, D.; Liu, S.; Zhang, C.; He, J.; Zhou, Z. Y.; Zhang, H.; Hu, Y. Hypoxia-targeting, tumor microenvironment responsive nanocluster bomb for radical-enhanced radiotherapy. ACS Nano 2017 11, 10159–10174. Guo, Z.; Zhu, S.; Yong, Y.; Zhang, X.; Dong, X. H.; Du, J. F.; Xie, J. N.; Wang, Q.; Gu, Z. J.; Zhao, Y. L. Synthesis of BSA-coated BiOI@Bi2S3 semiconductor heterojunction nanoparticles and their applications for radio/photodynamic/photothermal synergistic therapy of tumor. Adv. Mater. 2017 29, 1704136. Nam, J.; Son, S.; Ochyl, L. J.; Kuai, R.; Schwendeman, A.; Moon, J. J. Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer. Nat. Commun. 2018 9, 1074. Ng, C. W.; Li, J. C.; Pu, K. Y. Recent progresses in phototherapy-synergized cancer immunotherapy. Adv. Funct. Mater. 2018 28, 1804688. Pan, J. B.; Wang, Y. Q.; Zhang, C.; Wang, X. Y.; Wang, H. Y.; Wang, J. J.; Yuan, Y. Z.; Wang, X.; Zhang, X. J.; Yu, C. S. et al. Antigen-directed fabrication of a multifunctional nanovaccine with ultrahigh antigen loading efficiency for tumor photothermal-immunotherapy. Adv. Mater. 2018 30, 1704408. Ge, R.; Liu, C. W.; Zhang, X.; Wang, W. J.; Li, B. X.; Liu, J.; Liu, Y.; Sun, H. C.; Zhang, D. Q.; Hou, Y. C. et al. Photothermal-activatable Fe3O4 superparticle nanodrug carriers with PD-L1 immune checkpoint blockade for anti-metastatic cancer immunotherapy. ACS Appl. Mater. Interfaces 2018 10, 20342–20355. Ma, N.; Zhang, M. K.; Wang, X. S.; Zhang, L.; Feng, J.; Zhang, X. Z. NIR light-triggered degradable MoTe2 nanosheets for combined photothermal and chemotherapy of cancer. Adv. Funct. Mater. 2018 28, 1801139. Yang, J.; Zhai, S. D.; Qin, H.; Yan, H.; Xing, D.; Hu, X. L. NIRcontrolled morphology transformation and pulsatile drug delivery based on multifunctional phototheranostic nanoparticles for photoacoustic imagingguided photothermal-chemotherapy. Biomaterials 2018 176, 1–12. Zhang, Y. Y.; Yang, D.; Chen, H. Z.; Lim, W. Q.; Phua, F. S. Z.; An, G. H.; Yang, P. P.; Zhao, Y. L. Reduction-sensitive fluorescence enhanced polymeric prodrug nanoparticles for combinational photothermalchemotherapy. Biomaterials 2018 163, 14–24. Wang, D. D.; Dong, H. F.; Li, M.; Cao, Y.; Yang, F.; Zhang, K.; Dai, W. B.; Wang, C. T.; Zhang, X. J. Erythrocyte-cancer hybrid membrane camouflaged hollow copper sulfide nanoparticles for prolonged circulation life and homotypic-targeting photothermal/chemotherapy of melanoma. ACS Nano 2018 12, 5241–5252, DOI: 10.1021/acsnano.7b08355. Kim, J.; Yung, B. C.; Kim, W. J.; Chen, X. Y. Combination of nitric oxide and drug delivery systems: Tools for overcoming drug resistance in chemotherapy. J. Control. Release 2017 263, 223–230. Fan, W. P.; Yung, B. C.; Chen, X. Y. Stimuli-responsive no release for on-demand gas-sensitized synergistic cancer therapy. Angew. Chem., Int. Ed. 2018 57, 8383–8394. Hare, J. M.; Stamler, J. S. NO/redox disequilibrium in the failing heart and cardiovascular system. J. Clin. Invest. 2005 115, 509–517. Masterson, T. A.; Arora, H.; Kulandavelu, S.; Carroll, R. S.; Kaiser, U. B.; Gultekin, S. H.; Hare, J. M.; Ramasamy, R. S-nitrosoglutathione reductase (GSNOR) deficiency results in secondary hypogonadism. J. Sex. Med. 2018 15, 654–661. Garthwaite, J. Concepts of neural nitric oxide-mediated transmission. Eur. J. Neurosci. 2008 27, 2783–2802. Dulce, R. A.; Mayo, V.; Rangel, E. B.; Balkan, W.; Hare, J. M. Interaction between neuronal nitric oxide synthase signaling and temperature influences sarcoplasmic reticulum calcium leak: Role of nitroso-redox balance. Circ. Res. 2015 116, 46–55. Lundberg, J. O.; Gladwin, M. T.; Weitzberg, E. Strategies to increase nitric oxide signalling in cardiovascular disease. Nat. Rev. Drug Discov. 2015 14, 623–641. Deepagan, V. G.; Ko, H.; Kwon, S.; Rao, N. V.; Kim, S. K.; Um, W.; Lee, S.; Min, J.; Lee, J.; Choi, K. Y. et al. Intracellularly activatable nanovasodilators to enhance passive cancer targeting regime. Nano Lett 2018 18, 2637–2644. Wei, G. Q.; Wang, Y.; Huang, X. H.; Yang, G.; Zhao, J. Y.; Zhou, S. B. Enhancing the accumulation of polymer micelles by selectively dilating tumor blood vessels with no for highly effective cancer treatment. Adv. Healthc. Mater. 2018 7, 1801094. Yang, T.; Zelikin, A. N.; Chandrawati, R. Progress and promise of nitric oxide-releasing platforms. Adv. Sci. 2018 5, 1701043. Jin, Z. K.; Wen, Y. Y.; Hu, Y. X.; Chen, W. W.; Zheng, X. F.; Guo, W. S.; Wang, T. F.; Qian, Z. Y.; Su, B. L.; He, Q. J. MRI-guided and ultrasoundtriggered release of NO by advanced nanomedicine. Nanoscale 2017 9, 3637–3645. Jia, X. B.; Zhang, Y. H.; Zou, Y.; Wang, Y.; Niu, D. C.; He, Q. J.; Huang, Z. J.; Zhu, W. H.; Tian, H.; Shi, J. L. et al. Dual intratumoral redox/ enzymeresponsive NO-releasing nanomedicine for the specific, high-efficacy, and low-toxic cancer therapy. Adv. Mater. 2018 30, 1704490. Zhang, K.; Xu, H. X.; Jia, X. Q.; Chen, Y.; Ma, M.; Sun, L. P.; Chen, H. R. Ultrasound-triggered nitric oxide release platform based on energy transformation for targeted inhibition of pancreatic tumor. ACS Nano 2016 10, 10816–10828. Guo, R. R.; Tian, Y.; Wang, Y. J.; Yang, W. L. Near-infrared laser-triggered nitric oxide nanogenerators for the reversal of multidrug resistance in cancer. Adv. Funct. Mater. 2017 27, 1606398. Chen, L. J.; He, Q. J.; Lei, M. Y.; Xiong, L. W.; Shi, K.; Tan, L. W.; Jin, Z. K.; Wang, T. F.; Qian, Z. Y. Facile coordination-precipitation route to insoluble metal Roussin’s black salts for NIR-responsive release of NO for anti-metastasis. ACS Appl. Mater. Interfaces 2017 9, 36473–36477. Beckman, J. S.; Koppenol, W. H. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am. J. Physiol. 1996, 271, C1424–C1437. Thomas, D. D. Breathing new life into nitric oxide signaling: A brief overview of the interplay between oxygen and nitric oxide. Redox Biol. 2015 5, 225–233. Bourassa, J. L.; Ford, P. C. Flash and continuous photolysis studies of Roussin’s red salt dianion Fe2S2(NO)4 2- in solution. Coord. Chem. Rev. 2000, 200-202, 887–900. Bourassa, J.; DeGraff, W.; Kudo, S.; Wink, D. A.; Mitchell, J. B.; Ford, P. C. Photochemistry of Roussin’s red salt, Na2[Fe2S2(NO)4], and of Roussin’s black salt, NH4[Fe4S3(NO)7], in situ nitric oxide generation to sensitize γ-radiation induced cell death. J. Am. Chem. Soc. 1997 119, 2853–2860. Janczyk, A.; Wolnicka-Glubisz, A.; Chmura, A.; Elas, M.; Matuszak, Z.; Stochel, G.; Urbanska, K. NO-dependent phototoxicity of Roussin’s black salt against cancer cells. Nitric Oxide 2004 10, 42–50. Yan, L. S.; Amirshaghaghi, A.; Huang, D.; Miller, J.; Stein, J. M.; Busch, T. M.; Cheng, Z. L.; Tsourkas, A. Protoporphyrin IX (PpIX)-coated superparamagnetic iron oxide nanoparticle (SPION) nanoclusters for magnetic resonance imaging and photodynamic therapy. Adv. Funct. Mater. 2018 28, 1707030. Jin, C. S.; Lovell, J. F.; Chen, J.; Zheng, G. Ablation of hypoxic tumors with dose-equivalent photothermal, but not photodynamic, therapy using a nanostructured porphyrin assembly. ACS Nano 2013 7, 2541–2550. Conrado, C. L.; Wecksler, S.; Egler, C.; Magde, D.; Ford, P. C. Synthesis and photochemical properties of a novel iron-sulfur-nitrosyl cluster derivatized with the pendant chromophore protoporphyrin IX. Inorg. Chem. 2004 43, 5543–5549. Fuhrhop, J. H.; Demoulin, C.; Boettcher, C.; Koening, J.; Siggel, U. Chiral micellar porphyrin fibers with 2-aminoglycosamide head groups. J. Am. Chem. Soc. 1992 114, 4159–4165. Seo, J.; Jang, J.; Warnke, S.; Gewinner, S.; Schöllkopf, W.; von Helden, G. Stacking geometries of early protoporphyrin IX aggregates revealed by gas-phase infrared spectroscopy. J. Am. Chem. Soc. 2016 138, 16315–16321. Wecksler, S.; Mikhailovsky, A.; Ford, P. C. Photochemical production of nitric oxide via two-photon excitation with NIR light. J. Am. Chem. Soc. 2004 126, 13566–13567. Qu, Q. Q.; Wang, Y.; Zhang, L.; Zhang, X. B.; Zhou, S. B. A nanoplatform with precise control over release of cargo for enhanced cancer therapy. Small 2016 12, 1378–1390. Mallory, M.; Gogineni, E.; Jones, G. C.; Greer, L.; Simone II, C. B. Therapeutic hyperthermia: The old, the new, and the upcoming. Crit. Rev. Oncol. Hematol. 2016 97, 56–64. Shah, B. P.; Pasquale, N.; De, G. J.; Tan, T.; Ma, J. J.; Lee, K. B. Core-shell nanoparticle-based peptide therapeutics and combined hyperthermia for enhanced cancer cell apoptosis. ACS Nano 2014 8, 9379–9387. Cooper, C. E.; Giulivi, C. Nitric oxide regulation of mitochondrial oxygen consumption II: Molecular mechanism and tissue physiology. Am. J. Physiol. Cell Physiol. 2007, 292, C1993–C2003. Elfering, S. L.; Sarkela, T. M.; Giulivi, C. Biochemistry of mitochondrial nitric-oxide synthase. J. Biol. Chem. 2002 277, 38079–38086.